Titan Medical Inc TMDIF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TMDIF is a good fit for your portfolio.
News
-
Titan Provides Update on Planned Merger with Conavi
-
Titan Medical Reports Financial Results for the First Quarter 2024
-
Titan Provides Update on Planned Merger with Conavi
-
Titan Settles Contractual Dispute with Contract Manufacturer
-
Titan Medical Reports Fiscal Year 2023 Results
-
Titan Announces Q&A Session with Shareholders
-
Titan Announces Merger Agreement with Conavi
-
Titan Medical to Report Year-End 2023 Financial Results on March 29, 2024
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.03–0.04
- 52-Week Range
- $0.03–0.19
- Bid/Ask
- $0.04 / $0.04
- Market Cap
- $3.99 Mil
- Volume/Avg
- 4,243 / 107,079
Key Statistics
- Price/Earnings (Normalized)
- 0.71
- Price/Sales
- 0.24
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 4
- Website
- https://www.titanmedicalinc.com
Valuation
|
Metric
|
TMDIF
|
|---|---|
Price/Earnings (Normalized) | 0.71 |
Price/Book Value | 2.60 |
Price/Sales | 0.24 |
Price/Cash Flow | 0.50 |
Price/Earnings
TMDIF
Financial Strength
|
Metric
|
TMDIF
|
|---|---|
Quick Ratio | 2.45 |
Current Ratio | 2.78 |
Interest Coverage | 31.18 |
Quick Ratio
TMDIF
Profitability
|
Metric
|
TMDIF
|
|---|---|
Return on Assets (Normalized) | 113.73% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 253.45% |
Return on Assets
TMDIF
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Rmmmhwrfg | Rqtnzd | $181.1 Bil | |
SYK
| Stryker Corp | Lllxzxsf | Hwj | $127.5 Bil | |
MDT
| Medtronic PLC | Mzbsnbpf | Lhdpb | $113.7 Bil | |
BSX
| Boston Scientific Corp | Hxjgwghh | Zyrrrs | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Fbpmccqcxn | Mklws | $54.3 Bil | |
DXCM
| DexCom Inc | Bksqzhbwr | Twngm | $52.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Ftqgvbyl | Ybpvxr | $26.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Pdzdtrhwl | Jvyl | $24.7 Bil | |
ALGN
| Align Technology Inc | Pbcdfxttc | Bjswh | $20.6 Bil | |
PODD
| Insulet Corp | Rghncpxwqj | Rfrmklf | $13.1 Bil |